DRTB-HDT SIGNED
STRATIFIED HOST-DIRECTED THERAPY FOR DRUG-RESISTANT TUBERCULOSIS: A RANDOMIZED CONTROLLED MULTI-CENTRE TRIAL
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0DRTB-HDT project word cloud
Explore the words cloud of the DRTB-HDT project. It provides you a very rough idea of what is the project "DRTB-HDT" about.
Project "DRTB-HDT" data sheet
The following table provides information about the project.
| Coordinator |
SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT
Organization address contact info |
| Coordinator Country | Switzerland [CH] |
| Total cost | 9˙969˙012 € |
| EC max contribution | 9˙969˙012 € (100%) |
| Programme |
1. H2020-EU.3.1.3. (Treating and managing disease) |
| Code Call | H2020-SC1-2019-Two-Stage-RTD |
| Funding Scheme | RIA |
| Starting year | 2020 |
| Duration (year-month-day) | from 2020-01-01 to 2023-12-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT | CH (Basel) | coordinator | 1˙155˙060.00 |
| 2 | THE AURUM INSTITUTE NPC | ZA (PARKTOWN JOHANNESBURG) | participant | 3˙200˙656.00 |
| 3 | WITS HEALTH CONSORTIUM (PTY) LTD | ZA (Johannesburg) | participant | 1˙752˙440.00 |
| 4 | Instituto Nacional de Saúde | MZ (Maputo) | participant | 868˙332.00 |
| 5 | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN | DE (MUENCHEN) | participant | 808˙922.00 |
| 6 | FORSCHUNGSZENTRUM BORSTEL | DE (BORSTEL) | participant | 753˙750.00 |
| 7 | NATIONAL CENTER FOR TUBERCULOSIS AND LUNG DISEASES JSC | GE (TBILISI) | participant | 618˙000.00 |
| 8 | INSTITUTUL DE PNEUMOFTIZIOLOGIE MARIUS NASTA | RO (BUCURESTI) | participant | 353˙750.00 |
| 9 | UNIVERSITEIT ANTWERPEN | BE (ANTWERPEN) | participant | 275˙199.00 |
| 10 | "INSTITUTIA MEDICO-SANITARA PUBLICA - INSTITUTUL DE FTIZIOPNEUMOLOGIE ""CHIRIL DRAGANIUC""" | MD (CHISINAU) | participant | 182˙901.00 |
Map
Project objective
Tuberculosis is a leading cause of morbidity and mortality worldwide. Current TB treatments are inadequate, requiring patients closely adhere to multi-drug regimens that are long, complex, and often poorly tolerated. These concerns are greatly magnified in rifampicin-resistant (RIF-R) TB, an urgent global and EU public health priority. WHO estimates that only 54% of patients who began RIF-R TB treatment in 2016 were cured. In addition to these well-recognized shortcomings, current TB treatments, particularly those for RIF-R TB, leave a majority of cured patients with permanent, clinically significant lung impairment and radiographic evidence of bronchiectasis and fibrosis. This project will determine if two adjunctive host-directed therapies (HDTs) can prevent these poor outcomes. 330 patients with RIF-R TB and baseline risk factors for poor outcome will be enrolled in a randomized, controlled, 3-armed multi-centre trial, with clinical sites in Germany, Romania, Moldova, Georgia, Mozambique, and South Africa. All patients will receive standard multidrug therapy according to national guidelines. Those patients randomized to the experimental arms will in addition receive either CC-11050 or metformin. These selected HDT candidates represent 2 complementary HDT strategies: reducing inflammation vs inducing host cell anti-microbial activity, respectively. Both candidates are supported by data from preclinical and clinical studies. Co-primary efficacy endpoints will examine effects on lung function (measured by spirometry) and infection (measured as time to stable sputum culture conversion). A sub-study will examine quantitative change in lung radiodensity by CT scan. If successful, this ground-breaking project will increase Europe’s capacity to control RIF-R-TB by developing new treatments that increase the likelihood of cure and reduce the risk of life-long disability.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DRTB-HDT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "DRTB-HDT" are provided by the European Opendata Portal: CORDIS opendata.